Background
The American Association for Thoracic Surgery is organizing open discussions in cardiothoracic treatment and care. This time the focus was on the State of the art in coronary bypass grafting.
Content
Important issues to be discussed was bilateral internal thoracic artery grafts, stroke prevention and no-touch, saphenous vein grafts, graft indications, vein graft patency, off-pump surgery, minimally invasive coronary artery bypass, hybrid procedures, graft assessment and robotic procedures.
Important Quotes
Stroke prevention: There is absolutely no excuse why every patient shouldn't have epiaortic scanning (Dr. Mack)
The greatest mistake we OPCAB enthusiasts have made was for a decade to put a partial occlusion clamp on a pulsatile aorta and to think that was somehow minimally invasive (Dr. Puskas) Epiaortic scanning is very important in preventing embolization (Dr. Sabik) Off-pump surgery: There is currently no evidence to show that OPCAB, MIDCAB, or hybrid procedures result in any superior outcomes compared to on-pump procedures (Dr.Lazar) For patients at low risk for cardiopulmonary bypass, there is no survival benefit with off-pump bypass (Dr. Puskas)
The problem is I think there are a small minority of patients who really do benefit from off-pump surgery (Dr. Taggart)
Internal thoracic artery grafts:
The most important thing we do as heart surgeons and as coronary surgeons is placing the LIMA to the LAD (Dr. Sabik)
The recommendation that many of us have signed onto is that 70% stenosis is reasonable to graft the vessel. There is little data to support this (Dr. Sabik) Graft patency: There's no question that all graft patency, especially vein graft patency, will be improved if these patients are kept on aggressive statin regimens (Dr. Lazar)
The concerns about graft patency and completeness of revascularization in inexperienced hands are real (Dr. Puskas)
I think as a standard of care, every patient should have measurement of the IMA to LAD flow and check that anastomosis, because it's the one thing in all of coronary revascularization that changes a patient's life expectancy (Dr. Taggart)

Medistim Comments
During the state-of-the art discussion, Dr. Taggart also made the following comment: The recommendation given by Dr. David Taggart regarding graft patency, points to the importance of combining both epicardial imaging and TTFM for a complete intraoperative quality assessment of the graft and the anastomosis. The VeriQ C™ system provides the state-of-the-art technology device to accommodate these recommendations.
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